Client Stories
Sofiprotéol supports Ceva Santé Animale new buy-out
Investec has advised Sofiprotéol on its investment into Ceva Santé Animale, alongside historical shareholders and new investors
About the deal
Ceva Santé Animale, the world’s fifth largest animal health company, has renewed its shareholding structure with all its long-standing historical shareholders and welcomes Institut Mérieux and Archimed to accelerate its growth. Family shareholders and long-term financial partners, including historical investors led by Temasek, have renewed their investment, demonstrating their confidence in the Group’s ability to pursue its sustained growth.
Ceva Santé Animale management, led by Dr. Marc Prikazsky, has strengthened its stake and retained the majority of voting rights, thus confirming its commitment to remain independent. It is supported by a core group of long-term investors such as the Mérieux and Bettencourt-Meyers families as well as Sofiprotéol, ensuring a stable shareholder base committed to the Group’s development and supporting innovation in animal health.
Sofiprotéol has been supporting Ceva since 2014 and has renewed its commitment to support Ceva’s long-term project as a minority investor. Sofiprotéol continues to contribute to the Group’s shareholding stability and supporting its development with innovative health solutions and preventive medicine.
Our role
Investec has advised Sofiprotéol on its equity investment into Ceva Santé Animale, including:
- Providing critical analysis of the investment,
- Valuation guidance,
- Execution support,
- Negotiation of the transaction terms and conditions.
About Ceva Santé Animale
With 7,000 employees and €1.8bn revenues, Ceva Santé Animale is a global leader in animal health, particularly in the field of vaccination. Operating in 47 countries, the Group distributes its products worldwide to veterinarians, livestock professionals (ruminants, swine, poultry) and pet owners.
About Sofiprotéol
Sofiprotéol is an investment company, the sustainable financing subsidiary of Avril (€7.7bn revenues in FY24), dedicated to the agricultural and food sectors, and offering tailerod financing solutions to support growth projects. Its objective has always been to create long-term value, with a view to ensuring sustainable food and preserving the planet.